Real-World Utilization of Palbociclib as First-Line Treatment for Canadian HR+/HER2− Women with Metastatic Breast Cancer: Results from PALCAN Study.

Simple Summary: There is limited Canadian real-world data that shows how palbociclib, a first-line treatment for hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer, is being used in Canadian women. Using health administrative data from Alberta, Cana...

Full description

Bibliographic Details

Published in:	Current Oncology Vol. 31; no. 2; pp. 81 - 93
Main Authors:	Rayson, Daniel, Bertin, Jonathan, Lemelin, Maxim, Tong, Madeline, Ng, Ryan, Ding, Philip, Cheung, Winson Y., Sharma, Arushi, On, Phu Vinh, Feugère, Guillaume, Lupichuk, Sasha
Format:	Journal Article
Published:	MDPI Feb2026
Online Access:	View this record in EBSCOhost